Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients
In our cohort of hospitalized children with COVID-19 who were treated with remdesivir, most patients experienced only mild transaminitis and normal creatinine concentrations. A limited number of patients experienced laboratory abnormalities which were transient, suggesting a favorable safety profile for remdesivir use in pediatrics.
Authors
- Katie Ray
- Brittany Player (ORCID: https://orcid.org/0000-0001-7287-053X)
- Michelle Mitchell (ORCID: https://orcid.org/0000-0002-0320-5162)
- Amy Pan (ORCID: https://orcid.org/0000-0002-7199-7704)
- Anna R. Huppler (ORCID: https://orcid.org/0000-0003-1263-6623)
- Kelly Graff (ORCID: https://orcid.org/0000-0002-1875-9221)
- Peter L. Havens
- Melodee Liegl
Institutions
- Children's Hospital of Wisconsin (US)
- Medical College of Wisconsin (US)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1186/s12879-024-09833-9
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.78